Shire Global

As one of the world’s leading specialty biopharmaceutical companies, Shire has emerged as a company fully focused on a single purpose:  to enable people with life-altering conditions to lead better lives.

Through our Shire Human Genetic Therapies business we pursue treatment opportunities on behalf of patients and families facing rare diseases such as Fabry Disease, a lysosomal storage disorder and hereditary angioedema - patients whose lives and well being often hinge on the discovery and delivery of critical medicines.

Through our Specialty Pharma business we develop and distribute an innovative portfolio of treatments for patients with ADHD, ulcerative colitis, and end-stage renal disease.  Our commitment throughout is on symptomatic diseases, treated by specialist physicians.

Strategic partnerships have fueled Shire’s rapid growth—acquisitions and mergers designed to fortify development as well as marketed portfolios.  In the twenty plus years of Shire’s short history, the majority of our new products have joined our stable of existing medicines via an acquisition or partnership. The only exception being our HGT business, where development of enzyme replacement therapies from early phases is lower risk than the discovery of small molecules and we have an active in-house early research capability.

At the same time, Shire has systematically extended its global reach by building operations in other global locations.  By offering a range of essential medicines to patients all over the world, Shire has gained a reputation as a company that delivers on the promises it makes.
 
We also care, at Shire, about the communities in which we live and work—about who we are and the legacy we leave behind.  Through countless Corporate Responsibility initiatives, we’re making a difference by supporting programs ranging from the education of young scientists and the beautifying of natural landscapes to the reduction of CO2 emissions and the development of a green-oriented employee family.

At Shire we are perpetually planning for the future.  We’re exploring new markets.  We’re conversing with thought leaders.  We’re listening to patients and families, to innovators and inventors.  We’re asking ourselves what more we can do to make this world a healthier place and in doing so, we’re mindful of our overall cultural ethos; to be as brave as the people we help.

To learn more, please visit the Shire Corporate website at www.shire.com .